多房囊性肾细胞癌诊治分析(附21例报告)  

Diagnosis and Treatment of Multilocular Cystic Renal Cell Carcinoma(Report of 21 Cases)

作　　者：方林[1] 

机构地区：[1]厦门大学附属中山医院泌尿外科,福建省厦门市361004

出　　处：《医学理论与实践》2017年第11期1579-1581,共3页The Journal of Medical Theory and Practice

摘　　要：目的:探讨多房囊性肾细胞癌的诊断及治疗方法。方法:回顾性分析2006年2-7月收治21例多房囊性肾细胞癌患者的临床症状和体征、影像学表现、手术方式、病理结果及预后情况。结果:13例行根治性肾切除术,8例行保留肾单位手术。术后病理报告均为多房囊性肾细胞癌。19例获随访,平均随访30.3个月,未见肿瘤复发和转移。结论:多房囊性肾细胞癌是一种低度恶性的肾肿瘤,预后良好;无特殊临床表现,诊断主要依靠影像学检查,Bosniak分类有助于提高术前诊断的准确率;保留肾单位手术是多房囊性肾癌的首选治疗方式。Objective： To investigate the diagnosis and treatment of multilocular cystic renal cell carcinoma（MCRCC）. Methods：The clinical data of symptom and sign, imaging characteristics, surgical approaches, pathology and prognosis of 21 cases with MCRCC treated from February 2006 to July 2016 were analyzed retrospectively. Results： Radical nephrectomy was performed in 13 cases and nephron sparing surgery was performed in 8 cases. Postoperative pathological ex amination of all 21 cases showed MCRCC. 19 cases were followed up. The mean follow-up period is 30. 3 months, there was no recurrence or metastasis observed. Conclusion： MCRCC is characterized as lower malignant potential with a favorable prognosis. MCRCC has no specific clinical characteristic. The diagnosis of MCRCC depends on imaging. Bosniak classification can be useful to prompt the accuracy of diagnosis before operation. Nephron sparing surgery is the preferred treatment for MCRCC.

关 键 词：多房囊性肾细胞癌 Bosniak分类 保留肾单位手术 

分 类 号：R737.11[医药卫生—肿瘤]